Immune system polymorphisms and factor VIII inhibitor formation in Brazilian haemophilia A severe patients

被引：6
|
作者：
Agostini, D. [1 ]
Rosset, C. [1 ]
Botton, M. R. [1 ]
Kappel, D. B. [1 ]
Vieira, I. A. [1 ]
Gorziza, R. P. [1 ]
Salzano, F. M. [1 ]
Bandinelli, E. [1 ]
机构：
[1] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-91501970 Porto Alegre, RS, Brazil
来源：
HAEMOPHILIA | 2012年 / 18卷 / 06期
关键词：
DISEASE; IMPACT; GENES;
D O I：
10.1111/hae.12015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e416 / e418
页数：3
相关论文
共 50 条
  • [31] Factor VIII inhibitor eradication with bortezomib in acquired haemophilia A
    McFadyen, James D.
    Huyen Tran
    Kaplan, Zane S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (06) : 986 - 987
  • [32] Optimizing efficacy of factor VIII prophylaxis for severe haemophilia A
    Fischer, K.
    HAEMOPHILIA, 2011, 17 : 9 - 15
  • [33] Immune tolerance induction in haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study (ObsITI)
    Ettingshausen, Carmen Escuriola
    Berntorp, Erik
    Dargaud, Yesim
    Gutowski, Zeynep
    Lacroix-Desmazes, Sebastien
    Negrier, Claude
    Pavlova, Anna
    Schved, Jean-Francois
    Lavigne-Lissalde, Geraldine
    Oldenburg, Johannes
    HAEMOPHILIA, 2016, 22 : 124 - 124
  • [34] Factor VIII inhibitors in patients with congenital severe haemophilia A and its relation to genotype
    Pio, S. F.
    Ozelo, M. C.
    Dos Santos, A.
    De Carvalho, B. V.
    Caram, C.
    Zouain, D.
    Oliveira, G. C.
    Rezende, S. M.
    HAEMOPHILIA, 2012, 18 (06) : e411 - e414
  • [35] HLA class II profile: A weak determinant of factor VIII inhibitor development in severe haemophilia A
    Hay, CRM
    Ollier, W
    Pepper, L
    Cumming, A
    Keeney, S
    Goodeve, AC
    Colvin, BT
    Hill, FGH
    Preston, FE
    Peake, IR
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (02) : 234 - 237
  • [36] Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies
    Volkers, Peter
    Hanschmann, Kay-Martin
    Calvez, Thierry
    Chambost, Herve
    Collins, Peter W.
    Demiguel, Virginie
    Hart, Daniel P.
    Hay, Charles R. M.
    Goudemand, Jenny
    Ljung, Rolf
    Palmer, Ben P.
    Santagostino, Elena
    van Hardeveld, Ella M.
    van den Berg, Marijke
    Keller-Stanislawski, Brigitte
    HAEMOPHILIA, 2019, 25 (03) : 398 - 407
  • [37] Joint bleeds increase the inhibitor response to human factor VIII in a rat model of severe haemophilia A
    Lovgren, K. M.
    Sondergaard, H.
    Skov, S.
    Wiinberg, B.
    HAEMOPHILIA, 2016, 22 (05) : 772 - 779
  • [38] HLA class II profile: A determinant of factor VIII inhibitor development in severe haemophilia A.
    Hay, CRM
    Ollier, W
    Pepper, L
    Cumming, A
    Keeney, S
    Goodeve, AC
    Peake, IR
    BLOOD, 1996, 88 (10) : 1306 - 1306
  • [39] Hla class II profile: A determinant of factor VIII inhibitor development in severe haemophilia A.
    Hay, CRM
    Ollier, W
    Pepper, L
    Cumming, A
    Preston, FE
    Hill, FGH
    Colvin, BT
    Ludlam, CA
    Peake, IR
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 231 - 231
  • [40] Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors
    Unuvar, A
    Warrier, I
    Lusher, JM
    HAEMOPHILIA, 2000, 6 (03) : 150 - 157
12345